Angionetics Competitors and Similar CompaniesClear all
Angionetics's competitors and similar companies include Variant Bio.
 Angionetics Angionetics is a company focused on the late-stage clinical development and commercialization of Generx, an angiogenic gene therapy product candidate designed for medical revascularization for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. | ||
Type | Type Subsidiary | Type Private |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Seattle, US HQ |
Employees | Employees N/A | Employees 47 |
For sources of this data, please see the company profile
View Company Profiles
Variant Bio
HQ
Seattle, US
Employees
47
Variant Bio is a biotechnology company that develops human genetic diversity therapies.
View company